FDA Approves Blood-Based Test for Colorectal Cancer Screening

The FDA has approved a blood-based test for colorectal cancer screening, offering a non-invasive alternative to traditional colonoscopy-based approaches. This regulatory clearance opens a new market category for liquid biopsy diagnostics in cancer prevention.

This Wire brief sits within Fusion42's coverage of Diagnostics. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.